Piramal Pharma Limited (BOM:543635)

Market Cap	249.28B
Revenue (ttm)	91.34B
Net Income (ttm)	980.70M
Shares Out	n/a
EPS (ttm)	0.73
PE Ratio	254.18
Forward PE	89.91
Dividend	0.14 (0.07%)
Ex-Dividend Date	Jul 16, 2025

Volume	386,913
Average Volume	252,254
Open	194.05
Previous Close	195.20
Day's Range	187.15 - 194.95
52-Week Range	180.35 - 307.85
Beta	n/a
RSI	36.97
Earnings Date	Oct 28, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, inje...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 5,476
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543635

Financial Performance

In 2024, Piramal Pharma's revenue was 91.51 billion, an increase of 11.99% compared to the previous year's 81.71 billion. Earnings were 911.30 million, an increase of 411.39%.